# The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia

> **NCT02868814** · PHASE3 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Pregabalin Release Tablets
- **DRUG:** Pregabalin Release Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02868814
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2016-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02868814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02868814, "The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02868814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*